San Diego-primarily based Viking Therapeutics marked itself as a significant competitor inside the weight loss drug market place in February immediately after revealing promising info from the mid-phase trial of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when presented as a weekly injection As well